Brief: NextCure To Temporarily Delay Starting NC318 Combination Clinical Trial In Lung Cancer
April 13 (Reuters) - NextCure Inc NXTC.O :
* NEXTCURE PROVIDES UPDATE ON CLINICAL TRIAL ACTIVITIES DUE
TO
IMPACT OF COVID-19 PANDEMIC
* NEXTCURE - TO TEMPORARILY DELAY STARTING NC318 COMBINATION
CLINICAL TRIAL IN NON-SMALL CELL LUNG CANCER WITH
STANDARD-OF-CARE CHEMOTHERAPIES
* NEXTCURE INC - TO TEMPORARILY DELAY INITIATING PHASE 1
PORTION
OF A PHASE 1/2 CLINICAL TRIAL FOR NC410
Source text for Eikon: ID:nGNX1z3Hnq
Further company coverage: NXTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NextCure
See all newsBrief: Xcellon Biologics Co Acquires Gmp Manufacturing Facility From Nextcure
NextCure Inc reports results for the quarter ended June 30 - Earnings Summary
NextCure Q2 net loss narrows on lower expenses
Brief: NextCure Q2 Net Income USD -14.892 Million
NextCure Inc expected to post a loss of $1.93 a share - Earnings Preview